US6020210A
(en)
*
|
1988-12-28 |
2000-02-01 |
Miltenvi Biotech Gmbh |
Methods and materials for high gradient magnetic separation of biological materials
|
US5385707A
(en)
*
|
1988-12-28 |
1995-01-31 |
Stefan Miltenyi |
Metal matrices for use in high gradient magnetic separation of biological materials and method for coating the same
|
EP0452342B1
(en)
*
|
1988-12-28 |
1994-11-30 |
MILTENYI, Stefan |
Methods and materials for high gradient magnetic separation of biological materials
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US5665582A
(en)
*
|
1990-10-29 |
1997-09-09 |
Dekalb Genetics Corp. |
Isolation of biological materials
|
AU8951191A
(en)
*
|
1990-10-29 |
1992-05-26 |
Dekalb Plant Genetics |
Isolation of biological materials using magnetic particles
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5186827A
(en)
*
|
1991-03-25 |
1993-02-16 |
Immunicon Corporation |
Apparatus for magnetic separation featuring external magnetic means
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US6664114B1
(en)
|
1992-08-03 |
2003-12-16 |
Sapidyne Instruments, Inc. |
Solid phase assay for detection of ligands
|
AU2593192A
(en)
|
1992-09-14 |
1994-04-12 |
Oystein Fodstad |
Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
|
WO1994020855A1
(en)
*
|
1993-03-04 |
1994-09-15 |
Sapidyne, Inc. |
Assay flow apparatus and method
|
US5868257A
(en)
*
|
1993-05-07 |
1999-02-09 |
Carpco, Inc. |
Magnetic separation systems
|
GB9309446D0
(en)
*
|
1993-05-07 |
1993-06-23 |
Carpco Sms Ltd |
Improvements in and relating to super-conducting magnets
|
US5514340A
(en)
*
|
1994-01-24 |
1996-05-07 |
Magnetix Biotechnology, Inc. |
Device for separating magnetically labelled cells
|
NO180658C
(no)
|
1994-03-10 |
1997-05-21 |
Oeystein Fodstad |
Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
|
DE4416784A1
(de)
*
|
1994-05-09 |
1995-11-30 |
Soft Gene Gmbh |
Methode zur Anreicherung von Zellen, die durch ballistischen Transfer modifiziert wurden
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
DE19516323C2
(de)
*
|
1995-04-27 |
1997-02-27 |
Dirk Dipl Chem Guenther |
Verfahren zur Herstellung von magnetisierbaren Dispersionen und deren Verwendung
|
DE19520298A1
(de)
*
|
1995-06-02 |
1996-12-05 |
Bayer Ag |
Sortiervorrichtung für biologische Zellen oder Viren
|
US5639669A
(en)
*
|
1995-06-07 |
1997-06-17 |
Ledley; Robert |
Separation of fetal cells from maternal blood
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
DE19528029B4
(de)
|
1995-07-31 |
2008-01-10 |
Chemagen Biopolymer-Technologie Aktiengesellschaft |
Magnetische Polymerpartikel auf der Basis von Polyvinylalkohol, Verfahren für ihre Herstellung und Verwendung
|
US6190870B1
(en)
|
1995-08-28 |
2001-02-20 |
Amcell Corporation |
Efficient enrichment and detection of disseminated tumor cells
|
US6140040A
(en)
*
|
1995-10-06 |
2000-10-31 |
Advanced Minerals Corporation |
Method of mechanically separating microparticles suspended in fluids using particulate media
|
NO961031D0
(no)
|
1996-03-13 |
1996-03-13 |
Det Norske Radiumshospital Tum |
Fremgangsmåte til å drepe uönskede målceller
|
DE19612001A1
(de)
|
1996-03-18 |
1997-09-25 |
Silica Gel Gmbh Adsorptions Te |
Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US7666308B2
(en)
*
|
1996-06-07 |
2010-02-23 |
Veridex, Llc. |
Magnetic separation apparatus and methods
|
EP0920627B1
(en)
*
|
1996-06-07 |
2004-05-12 |
Immunivest Corporation |
Magnetic separation employing external and internal gradients
|
US6660159B1
(en)
|
1996-06-07 |
2003-12-09 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6890426B2
(en)
*
|
1996-06-07 |
2005-05-10 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6790366B2
(en)
*
|
1996-06-07 |
2004-09-14 |
Immunivest Corporation |
Magnetic separation apparatus and methods
|
US6136182A
(en)
*
|
1996-06-07 |
2000-10-24 |
Immunivest Corporation |
Magnetic devices and sample chambers for examination and manipulation of cells
|
ATE211950T1
(de)
*
|
1996-08-05 |
2002-02-15 |
Schering Ag |
Vorrichtung und verfahren zur abtrennung magnetischer materialien aus pharmazeutischen zubereitungen, deren ausgangs- oder zwischenprodukten sowie mit hilfe dieser vorrichtung hergestellte mittel
|
US5817458A
(en)
*
|
1996-10-15 |
1998-10-06 |
The Avriel Group, Amcas Division Inc. |
Reagent system for detecting HIV-infected peripheral blood lymphocytes in whole blood
|
EP0933989A1
(en)
*
|
1996-10-15 |
1999-08-11 |
Bio-Tech Imaging, Inc. |
Reagent system and kit for detecting hiv infected cells
|
US5779892A
(en)
*
|
1996-11-15 |
1998-07-14 |
Miltenyi Biotec Gmbh |
Magnetic separator with magnetic compensated release mechanism for separating biological material
|
US5798206A
(en)
*
|
1997-01-10 |
1998-08-25 |
New York Blood Center |
Methods for screening of test compounds for inhibiting binding of a CD4-HIV 1 complex to a chemokine receptor
|
FR2758884B1
(fr)
|
1997-01-30 |
1999-04-02 |
Bio Merieux |
Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
|
US6241894B1
(en)
|
1997-10-10 |
2001-06-05 |
Systemix |
High gradient magnetic device and method for cell separation or purification
|
JP2000516345A
(ja)
|
1997-11-18 |
2000-12-05 |
バイオ―ラッド ラボラトリーズ インコーポレイテッド |
固相として磁性粒子を用いる多重フロー免疫検定
|
US6337215B1
(en)
*
|
1997-12-01 |
2002-01-08 |
International Business Machines Corporation |
Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
|
DE69934449T2
(de)
*
|
1998-03-12 |
2007-09-27 |
Miltenyi Biotech Gmbh |
Mikrokolonnen-System für Magnettrennung
|
US7220596B2
(en)
|
1998-04-15 |
2007-05-22 |
Utah State University |
Real time detection of antigens
|
DE69941150D1
(de)
|
1998-05-11 |
2009-09-03 |
Miltenyi Biotec Gmbh |
Verfahren zur direkten auswahl von antigen-spezifischen t-zellen
|
ATE404269T1
(de)
*
|
1998-11-30 |
2008-08-15 |
Immunivest Corp |
Verfahren und vorrichtung zur magnetischen trennung
|
US7364921B1
(en)
|
1999-01-06 |
2008-04-29 |
University Of Medicine And Dentistry Of New Jersey |
Method and apparatus for separating biological materials and other substances
|
US6159378A
(en)
*
|
1999-02-23 |
2000-12-12 |
Battelle Memorial Institute |
Apparatus and method for handling magnetic particles in a fluid
|
US6193892B1
(en)
|
1999-03-03 |
2001-02-27 |
Promega Corporation |
Magnetic separation assembly and method
|
CA2366543A1
(en)
*
|
1999-04-09 |
2000-10-19 |
John Vellinger |
Multistage electromagnetic separator for purifying cells, chemicals and protein structures
|
DE19938372A1
(de)
*
|
1999-08-09 |
2001-03-08 |
Diagnostikforschung Inst |
Verfahren und Vorrichtung zur Trennung magnetischer Teilchen
|
WO2001017687A2
(en)
*
|
1999-09-03 |
2001-03-15 |
Miltenyi Biotec Gmbh |
Methods of modification of selected cells in a magnetic cell separation column
|
US7169618B2
(en)
|
2000-06-28 |
2007-01-30 |
Skold Technology |
Magnetic particles and methods of producing coated magnetic particles
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
EP1325332B1
(en)
*
|
2000-10-03 |
2006-12-20 |
Minerva Biotechnologies Corporation |
Magnetic in situ dilution
|
US6649419B1
(en)
*
|
2000-11-28 |
2003-11-18 |
Large Scale Proteomics Corp. |
Method and apparatus for protein manipulation
|
FR2817967B1
(fr)
*
|
2000-12-08 |
2003-02-28 |
Diagast |
Procede de magnetisation de marqueurs chimiques ou biologiques
|
US20030095897A1
(en)
*
|
2001-08-31 |
2003-05-22 |
Grate Jay W. |
Flow-controlled magnetic particle manipulation
|
ATE438708T1
(de)
|
2001-11-15 |
2009-08-15 |
Childrens Medical Center |
Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon
|
US20030099954A1
(en)
*
|
2001-11-26 |
2003-05-29 |
Stefan Miltenyi |
Apparatus and method for modification of magnetically immobilized biomolecules
|
US7232691B2
(en)
*
|
2001-11-27 |
2007-06-19 |
Los Alamos National Security, Llc |
Bioassay and biomolecular identification, sorting, and collection methods using magnetic microspheres
|
WO2003049530A2
(en)
*
|
2001-12-07 |
2003-06-19 |
Dyax Corporation |
Method and apparatus for washing magnetically responsive particles
|
EP1494814A1
(en)
*
|
2002-04-12 |
2005-01-12 |
Instrumentation Laboratory Company |
Immunoassay probe
|
US9435799B2
(en)
*
|
2002-07-31 |
2016-09-06 |
Janssen Diagnostics, Inc. |
Methods and reagents for improved selection of biological materials
|
US20040067532A1
(en)
|
2002-08-12 |
2004-04-08 |
Genetastix Corporation |
High throughput generation and affinity maturation of humanized antibody
|
US7381561B2
(en)
|
2002-08-27 |
2008-06-03 |
Stemcells California, Inc. |
Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
|
US7601491B2
(en)
*
|
2003-02-06 |
2009-10-13 |
Becton, Dickinson And Company |
Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
|
DE10331439B3
(de)
*
|
2003-07-10 |
2005-02-03 |
Micromod Partikeltechnologie Gmbh |
Magnetische Nanopartikel mit verbesserten Magneteigenschaften
|
GB2423522A
(en)
*
|
2003-12-10 |
2006-08-30 |
Univ Utah Res Found |
Method for obtaining an enriched population of sirna-expressing cells
|
US20050266394A1
(en)
*
|
2003-12-24 |
2005-12-01 |
Massachusette Institute Of Technology |
Magnetophoretic cell clarification
|
US8211386B2
(en)
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
US9790539B2
(en)
*
|
2004-06-30 |
2017-10-17 |
Russell Biotech, Inc. |
Methods and reagents for improved selection of biological molecules
|
US20060024776A1
(en)
*
|
2004-08-02 |
2006-02-02 |
Mcmillian Ray |
Magnetic particle capture of whole intact organisms from clinical samples
|
WO2006017427A1
(en)
*
|
2004-08-03 |
2006-02-16 |
Becton, Dickinson And Company |
Use of magnetic material to fractionate samples
|
US7897257B2
(en)
*
|
2005-04-18 |
2011-03-01 |
Ge Healthcare Bio-Sciences Ab |
Magnetic beads comprising an outer coating of hydrophilic porous polymer and method of making thereof
|
EP1996931B1
(en)
|
2005-12-28 |
2013-11-27 |
The General Hospital Corporation |
Blood cell sorting methods and systems
|
WO2008016431A2
(en)
|
2006-07-29 |
2008-02-07 |
Robert Lamar Bjork |
Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug
|
WO2008103265A2
(en)
|
2007-02-16 |
2008-08-28 |
The Brigham And Women's Hospital, Inc. |
Methods of using ledgf/p75
|
DE102007043281A1
(de)
|
2007-09-11 |
2009-05-28 |
Sebastian Dr. med. Chakrit Bhakdi |
Vorrichtung, Materialien und Verfahren zur Hochgradientenmagnetseparation biologischen Materials
|
EP2193146B1
(en)
|
2007-09-14 |
2016-05-25 |
Adimab, LLC |
Rationally designed, synthetic antibody libraries and uses therefor
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
JP5456689B2
(ja)
|
2007-12-07 |
2014-04-02 |
ミルテンイ バイオテック ゲーエムベーハー |
試料を少なくとも2つの成分に分離する遠心分離機
|
US8338170B2
(en)
|
2008-04-21 |
2012-12-25 |
Viacyte, Inc. |
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
EP2283117B1
(en)
|
2008-04-21 |
2013-10-23 |
Viacyte, Inc. |
Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
|
EP2306959A2
(en)
*
|
2008-07-11 |
2011-04-13 |
The General Hospital Corporation |
Magnetic apparatus for blood separation
|
EP3363444B1
(en)
|
2008-11-14 |
2022-09-14 |
ViaCyte, Inc. |
Encapsulation of pancreatic cells derived from human pluripotent stem cells
|
EP2379711B8
(en)
|
2008-12-23 |
2017-03-22 |
BOCO Silicon Valley, Inc. |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
GB0823553D0
(en)
|
2008-12-24 |
2009-01-28 |
Immunosolv Ltd |
Cell separation technique
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
EP2454020B1
(en)
*
|
2009-07-17 |
2019-05-15 |
Koninklijke Philips N.V. |
Apparatus and method for the enrichment of magnetic particles
|
US8083069B2
(en)
*
|
2009-07-31 |
2011-12-27 |
General Electric Company |
High throughput magnetic isolation technique and device for biological materials
|
TWI362964B
(en)
*
|
2009-12-23 |
2012-05-01 |
Ind Tech Res Inst |
Magnetic separation device and method for separating magnetic substances in bio-samples
|
EP2390661B1
(en)
|
2010-05-02 |
2015-06-24 |
Miltenyi Biotec GmbH |
An anchoring/capturing means for selecting or analyzing a CHO cell according to a product secreted by the CHO cell
|
DE102011015321A1
(de)
|
2011-03-28 |
2012-10-04 |
Ralph Heindrichs |
Verfahren zur kontinuierlichen selektiven Separation von Partikeln mittels Magnetismus
|
EP2694965B1
(en)
|
2011-04-05 |
2017-01-18 |
Purdue Research Foundation |
Micro-fluidic system using micro-apertures for high throughput detection of entities
|
TWI407101B
(zh)
|
2011-04-11 |
2013-09-01 |
Ind Tech Res Inst |
磁分離單元、磁性分離裝置以及分離生化試樣內磁性物質之方法
|
BR112013024148B1
(pt)
|
2011-04-27 |
2022-01-25 |
Becton, Dickinson And Company |
Dispositivo, método e sistema para separar partes marcadas magneticamente em uma amostra, método de separar partes marcadas magneticamente em uma amostra
|
DK2597153T3
(en)
|
2011-11-25 |
2016-12-05 |
Miltenyi Biotec Gmbh |
Method for cell separation
|
DK2634195T3
(en)
|
2012-03-01 |
2017-02-27 |
Miltenyi Biotec Gmbh |
Separation of living pristine neurons
|
DE102012213032A1
(de)
*
|
2012-07-25 |
2014-01-30 |
Siemens Aktiengesellschaft |
Verfahren zum Entwässern einer wasserhaltigen Zellkultur
|
DK2890498T3
(en)
|
2012-08-29 |
2018-05-22 |
Inguran Llc |
MAGNETIC REMOVAL OR IDENTIFICATION OF DAMAGED OR COMPRIMATED CELLS OR CELL STRUCTURES
|
US10379026B2
(en)
|
2012-08-29 |
2019-08-13 |
Inguran, Llc |
Cell processing using magnetic particles
|
WO2014066553A1
(en)
|
2012-10-26 |
2014-05-01 |
Becton, Dickinson And Company |
Devices and methods for manipulating components in a fluid sample
|
EP2787006B1
(en)
|
2013-04-02 |
2018-02-28 |
Miltenyi Biotec GmbH |
Anti-CD8 antibody which binding is Ca2+ dependent
|
US9884326B2
(en)
*
|
2013-06-28 |
2018-02-06 |
National Institute Of Advanced Industrial Science And Technology |
Matrix for magnetic separator and magnetic separator
|
RU2763795C2
(ru)
|
2014-04-23 |
2022-01-11 |
Джуно Терапьютикс, Инк. |
Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
|
WO2015175562A1
(en)
|
2014-05-15 |
2015-11-19 |
Kellbenx Incorporated |
Preparation of fetal nucleated red blood cells (nrbcs) for diagnostic testing
|
EP2955521A1
(en)
|
2014-06-11 |
2015-12-16 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Methods for separating cells
|
US10738278B2
(en)
|
2014-07-15 |
2020-08-11 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
SG10202104804PA
(en)
|
2014-10-20 |
2021-06-29 |
Juno Therapeutics Inc |
Methods and compositions for dosing in adoptive cell therapy
|
PL3215601T3
(pl)
|
2014-11-05 |
2020-11-02 |
Juno Therapeutics, Inc. |
Sposoby transdukcji i przetwarzania komórek
|
EP3766895B1
(en)
|
2014-12-03 |
2024-07-10 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
CN107428833B
(zh)
|
2015-01-16 |
2021-11-02 |
朱诺治疗学股份有限公司 |
Ror1特异性抗体和嵌合抗原受体
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
CA2986060A1
(en)
|
2015-05-29 |
2016-12-08 |
Valerie Odegard |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
EP3365453A2
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods, kits, agents and apparatuses for transduction
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
WO2017079703A1
(en)
|
2015-11-05 |
2017-05-11 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
TWI673105B
(zh)
|
2015-11-18 |
2019-10-01 |
財團法人工業技術研究院 |
磁分離器
|
EP3383892B1
(en)
|
2015-12-03 |
2022-12-21 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
EP3383419B1
(en)
|
2015-12-03 |
2022-08-03 |
Juno Therapeutics, Inc. |
Compositions and methods for reducing immune responses against chimeric antigen receptors
|
ES2901795T3
(es)
|
2015-12-04 |
2022-03-23 |
Juno Therapeutics Inc |
Métodos y composiciones relacionadas con la toxicidad asociada con la terapia celular
|
IL259931B2
(en)
|
2015-12-16 |
2024-02-01 |
Gritstone Bio Inc |
Identification of neo-antigens, preparation, and use
|
WO2017161208A1
(en)
|
2016-03-16 |
2017-09-21 |
Juno Therapeutics, Inc. |
Methods for determining dosing of a therapeutic agent and related treatments
|
WO2017161212A1
(en)
|
2016-03-16 |
2017-09-21 |
Juno Therapeutics, Inc. |
Methods for adaptive design of a treatment regimen and related treatments
|
EP3433276B1
(en)
|
2016-03-22 |
2021-12-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Early intervention methods to prevent or ameliorate toxicity
|
EP4011381A1
(en)
|
2016-06-03 |
2022-06-15 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
US20200182884A1
(en)
|
2016-06-27 |
2020-06-11 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
US20190194283A1
(en)
|
2016-07-29 |
2019-06-27 |
Juno Therapeutics, Inc. |
Immunomodulatory polypeptides and related compositions and methods
|
EP3491152B1
(en)
|
2016-07-29 |
2022-06-29 |
Juno Therapeutics, Inc. |
Methods for assessing the presence or absence of replication competent virus
|
MX2019001184A
(es)
|
2016-07-29 |
2019-09-26 |
Juno Therapeutics Inc |
Anticuerpos anti-idiotípicos y métodos relacionados.
|
MA46053A
(fr)
|
2016-08-26 |
2019-07-03 |
Juno Therapeutics Inc |
Procédés de dénombrement de particules présentes dans une composition cellulaire
|
MX2019002765A
(es)
|
2016-09-12 |
2019-05-09 |
Juno Therapeutics Inc |
Montajes de bolsa de biorreactor de perfusion.
|
US11072660B2
(en)
|
2016-10-03 |
2021-07-27 |
Juno Therapeutics, Inc. |
HPV-specific binding molecules
|
MA46649A
(fr)
|
2016-10-13 |
2019-08-21 |
Juno Therapeutics Inc |
Méthodes et compositions d'immunothérapie impliquant des modulateurs de la voie métabolique du tryptophane
|
EP3534940A1
(en)
|
2016-11-03 |
2019-09-11 |
Juno Therapeutics, Inc. |
Combination therapy of a cell based therapy and a microglia inhibitor
|
MA46783A
(fr)
|
2016-11-03 |
2019-09-11 |
Juno Therapeutics Inc |
Polythérapie de type thérapie cellulaire t et inhibiteur de btk
|
EP3548622A1
(en)
|
2016-12-02 |
2019-10-09 |
Juno Therapeutics, Inc. |
Engineered b cells and related compositions and methods
|
JP2020511462A
(ja)
|
2016-12-03 |
2020-04-16 |
ジュノー セラピューティクス インコーポレイテッド |
キナーゼ阻害剤との組み合わせで治療用t細胞を使用するための方法および組成物
|
JP2019536460A
(ja)
|
2016-12-03 |
2019-12-19 |
ジュノー セラピューティクス インコーポレイテッド |
Car−t細胞の調節方法
|
US20200078400A1
(en)
|
2016-12-03 |
2020-03-12 |
Juno Therapeutics, Inc. |
Methods for determining car-t cells dosing
|
KR20190098747A
(ko)
|
2016-12-05 |
2019-08-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
입양 세포 치료법을 위한 조작된 세포의 제조방법
|
JP7429338B2
(ja)
|
2017-01-10 |
2024-02-08 |
ジュノー セラピューティクス インコーポレイテッド |
細胞療法および関連方法のエピジェネティック解析
|
CA3050085A1
(en)
|
2017-01-20 |
2018-07-26 |
Juno Therapeutics Gmbh |
Cell surface conjugates and related cell compositions and methods
|
IL268349B1
(en)
|
2017-02-17 |
2024-04-01 |
Hutchinson Fred Cancer Res |
Combination therapies for the treatment of BCMA-associated cancer and autoimmune disorders
|
CN110582287A
(zh)
|
2017-02-27 |
2019-12-17 |
朱诺治疗学股份有限公司 |
与在细胞疗法中给药有关的组合物、制品和方法
|
CA3056393A1
(en)
|
2017-03-14 |
2018-09-20 |
Juno Therapeutics, Inc. |
Methods for cryogenic storage
|
MX2019012017A
(es)
|
2017-04-07 |
2020-02-12 |
Juno Therapeutics Inc |
Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados.
|
MX2019012189A
(es)
|
2017-04-14 |
2020-12-10 |
Juno Therapeutics Inc |
Metodos para valorar la glucosilacion de la superficie celular.
|
US11866465B2
(en)
|
2017-04-27 |
2024-01-09 |
Juno Therapeutics Gmbh |
Oligomeric particle reagents and methods of use thereof
|
AU2018263887A1
(en)
|
2017-05-01 |
2019-11-21 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
MX2019014268A
(es)
|
2017-06-02 |
2020-08-03 |
Juno Therapeutics Inc |
Artículos de manufactura y métodos para tratamiento usando terapia celular adoptiva.
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
WO2018231373A1
(en)
*
|
2017-06-14 |
2018-12-20 |
Russell Biotech, Inc. |
Preparation of platelet free mononuclear cells
|
JP7145209B2
(ja)
|
2017-06-14 |
2022-09-30 |
ヘルムホルツ ツェントゥルム ミュンヘン ドイチェス フォルシュングスツェントゥルム フューア ゲズントハイト ウント ウムヴェルト (ゲーエムベーハー) |
ヒト胚性幹細胞から誘導された内胚葉及び膵内胚葉細胞を精製するための方法
|
EP3644721A1
(en)
|
2017-06-29 |
2020-05-06 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
US20230242654A1
(en)
|
2017-07-29 |
2023-08-03 |
Juno Therapeutics, Inc. |
Reagents for expanding cells expressing recombinant receptors
|
CA3070575A1
(en)
|
2017-08-09 |
2019-02-14 |
Juno Therapeutics, Inc. |
Methods and compositions for preparing genetically engineered cells
|
KR20200054178A
(ko)
|
2017-08-09 |
2020-05-19 |
주노 쎄러퓨티크스 인코퍼레이티드 |
유전자 조작된 세포 조성물 및 관련 조성물의 제조 방법
|
MA50057A
(fr)
|
2017-09-01 |
2020-07-08 |
Juno Therapeutics Inc |
Expression génique et évaluation d'un risque de développement d'une toxicité suite à une thérapie cellulaire
|
WO2019051335A1
(en)
|
2017-09-07 |
2019-03-14 |
Juno Therapeutics, Inc. |
METHODS OF IDENTIFYING CELLULAR CHARACTERISTICS RELATED TO RESPONSES ASSOCIATED WITH CELL THERAPY
|
MX2020003536A
(es)
|
2017-10-03 |
2020-09-14 |
Juno Therapeutics Inc |
Moleculas de union especifica a virus de papiloma humano (hpv).
|
WO2019075112A1
(en)
|
2017-10-10 |
2019-04-18 |
Gritstone Oncology, Inc. |
IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS
|
US20210254000A1
(en)
|
2017-11-01 |
2021-08-19 |
Juno Therapeutics, Inc. |
Process for producing a t cell composition
|
WO2019089848A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
SG11202003501XA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
MA50860A
(fr)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Récepterus chimériques d'antigène contre l'antigène de maturation des cellules b et polynucleotides codants
|
MA50855A
(fr)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Procédé de génération de compositions thérapeutiques de cellules modifiées
|
MA50564A
(fr)
|
2017-11-06 |
2020-09-16 |
Hutchinson Fred Cancer Res |
Association d'une thérapie cellulaire et d'un inhibiteur de gamma secrétase
|
US20200330983A1
(en)
|
2017-11-10 |
2020-10-22 |
Juno Therapeutics, Inc. |
Closed-system cryogenic vessels
|
CA3083097A1
(en)
|
2017-11-22 |
2019-05-31 |
Gritstone Oncology, Inc. |
Reducing junction epitope presentation for neoantigens
|
MA51210A
(fr)
|
2017-12-01 |
2020-10-07 |
Juno Therapeutics Inc |
Procédés de dosage et de modulation de cellules génétiquement modifiées
|
MX2020005907A
(es)
|
2017-12-08 |
2020-10-19 |
Juno Therapeutics Inc |
Formulacion de medio libre de suero para cultivar celulas y metodos de uso de la misma.
|
MA51114A
(fr)
|
2017-12-08 |
2020-10-14 |
Juno Therapeutics Inc |
Procédé de production d'une compositions de lymphocytes t modifiés
|
WO2019113559A2
(en)
|
2017-12-08 |
2019-06-13 |
Juno Therapeutics, Inc. |
Phenotypic markers for cell therapy and related methods
|
MA51184A
(fr)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics Inc |
Molécules de liaison à l'anti-cct5 et procédés d'utilisation associés
|
US11535903B2
(en)
|
2018-01-31 |
2022-12-27 |
Juno Therapeutics, Inc. |
Methods and reagents for assessing the presence or absence of replication competent virus
|
JP7383620B2
(ja)
|
2018-01-31 |
2023-11-20 |
セルジーン コーポレイション |
養子細胞療法およびチェックポイント阻害剤を使用する併用療法
|
JP7335883B2
(ja)
|
2018-02-28 |
2023-08-30 |
ジュノー セラピューティクス インコーポレイテッド |
細胞組成物中に存在する粒子を検出するための方法
|
WO2019170845A1
(en)
|
2018-03-09 |
2019-09-12 |
Ospedale San Raffaele S.R.L. |
Il-1 antagonist and toxicity induced by cell therapy
|
JP2021520202A
(ja)
|
2018-04-05 |
2021-08-19 |
ジュノー セラピューティクス インコーポレイテッド |
組換え受容体を発現する細胞の作製方法および関連組成物
|
CN112566698A
(zh)
|
2018-04-05 |
2021-03-26 |
朱诺治疗学股份有限公司 |
T细胞受体和表达该t细胞受体的工程化细胞
|
CN112585277A
(zh)
|
2018-04-05 |
2021-03-30 |
朱诺治疗学股份有限公司 |
表达重组受体的t细胞、相关多核苷酸和方法
|
KR20210044736A
(ko)
|
2018-05-03 |
2021-04-23 |
주노 쎄러퓨티크스 인코퍼레이티드 |
키메라 항원 수용체(car) t세포 요법과 키나제 억제제의 조합요법
|
CN113166221A
(zh)
|
2018-06-13 |
2021-07-23 |
阿科隆生物技术有限责任公司 |
制备在液体药物组合物中高度稳定的具有治疗活性的阿地白介素的方法
|
CN112805378A
(zh)
|
2018-08-09 |
2021-05-14 |
朱诺治疗学股份有限公司 |
用于评估整合核酸的方法
|
WO2020033927A2
(en)
|
2018-08-09 |
2020-02-13 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
EP3843778A1
(en)
|
2018-08-31 |
2021-07-07 |
Invectys Sa |
Chimeric antigen receptors against multiple hla-g isoforms
|
JP7504891B2
(ja)
|
2018-09-11 |
2024-06-24 |
ジュノー セラピューティクス インコーポレイテッド |
操作された細胞組成物のマススペクトロメトリー分析のための方法
|
SG11202103873VA
(en)
|
2018-11-01 |
2021-05-28 |
Juno Therapeutics Inc |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
MA54078A
(fr)
|
2018-11-01 |
2021-09-15 |
Juno Therapeutics Inc |
Méthodes pour le traitement au moyen de récepteurs antigéniques chimériques spécifiques de l'antigene de maturation des lymphocytes b
|
MX2021005021A
(es)
|
2018-11-06 |
2021-08-11 |
Juno Therapeutics Inc |
Proceso para producir celulas t geneticamente modificadas.
|
BR112021008930A2
(pt)
|
2018-11-08 |
2021-11-03 |
Juno Therapeutics Inc |
Métodos e combinações para o tratamento e modulação de célula t
|
BR112021009420A2
(pt)
|
2018-11-16 |
2021-11-23 |
Juno Therapeutics Inc |
Métodos de dosagem de células t manipuladas para o tratamento de malignidades de células b
|
MX2021006244A
(es)
|
2018-11-30 |
2021-09-10 |
Juno Therapeutics Inc |
Metodos de dosificacion y tratamiento de canceres de celulas b en terapia celular adoptiva.
|
MX2021006238A
(es)
|
2018-11-30 |
2021-10-01 |
Juno Therapeutics Inc |
Metodos para tratamiento que usan terapia celular adoptiva.
|
SG11202107976SA
(en)
|
2019-01-29 |
2021-08-30 |
Juno Therapeutics Inc |
Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
|
EP3693739A1
(de)
|
2019-02-06 |
2020-08-12 |
Stefan Schreier |
Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien
|
EP3962519A1
(en)
|
2019-05-01 |
2022-03-09 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified cd247 locus, related polynucleotides and methods
|
SG11202111360YA
(en)
|
2019-05-01 |
2021-11-29 |
Juno Therapeutics Inc |
Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methods
|
EP3963337A1
(en)
|
2019-05-02 |
2022-03-09 |
KellBenx Inc. |
Filtration-based methods for preparing fetal nucleated red blood cells (nrbcs) for diagnostic testing
|
EP3983006A1
(en)
|
2019-06-12 |
2022-04-20 |
Juno Therapeutics, Inc. |
Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
JP2022546396A
(ja)
|
2019-08-30 |
2022-11-04 |
ジュノー セラピューティクス インコーポレイテッド |
細胞を分類するための機械学習方法
|
CN115087868A
(zh)
|
2019-11-05 |
2022-09-20 |
朱诺治疗学股份有限公司 |
确定治疗性t细胞组合物的属性的方法
|
BR112022007548A2
(pt)
|
2019-11-07 |
2022-07-12 |
Juno Therapeutics Inc |
Combinação de uma terapia de célula t e (s)-3-[4-(4-morfolin-4-ilmetil-benzilóxi)-1-oxo-1,3-di-hidro-isoindol-2-il]-piperidina-2,6-diona
|
EP4070097A1
(en)
|
2019-12-06 |
2022-10-12 |
Juno Therapeutics, Inc. |
Methods related to toxicity and response associated with cell therapy for treating b cell malignancies
|
JP2023504736A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Gprc5d標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
MX2022006709A
(es)
|
2019-12-06 |
2022-09-12 |
Juno Therapeutics Inc |
Anticuerpos antiidiotípicos para dominios de unión dirigidos a bcma y métodos y composiciones relacionadas.
|
US20230071910A1
(en)
|
2020-01-24 |
2023-03-09 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment of follicular lymphoma and marginal zone lymphoma in adoptive cell therapy
|
EP4097218A1
(en)
|
2020-01-28 |
2022-12-07 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
EP4103203A1
(en)
|
2020-02-12 |
2022-12-21 |
Juno Therapeutics, Inc. |
Bcma-directed chimeric antigen receptor t cell compositions and methods and uses thereof
|
BR112022015236A2
(pt)
|
2020-02-12 |
2022-09-20 |
Juno Therapeutics Inc |
Composições de células t do receptor de antígeno quimérico direcionado a cd19 e métodos e usos das mesmas
|
US20230149462A1
(en)
|
2020-04-10 |
2023-05-18 |
Juno Therapeutics, Inc. |
Methods and uses related to cell therapy engineered with a chimeric antigen receptor targeting b-cell maturation antigen
|
WO2021222330A2
(en)
|
2020-04-28 |
2021-11-04 |
Juno Therapeutics, Inc. |
Combination of bcma-directed t cell therapy and an immunomodulatory compound
|
WO2021231661A2
(en)
|
2020-05-13 |
2021-11-18 |
Juno Therapeutics, Inc. |
Process for producing donor-batched cells expressing a recombinant receptor
|
US20230178239A1
(en)
|
2020-05-13 |
2023-06-08 |
Juno Therapeutics, Inc. |
Methods of identifying features associated with clinical response and uses thereof
|
US20240216508A1
(en)
|
2020-06-26 |
2024-07-04 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
KR20230095918A
(ko)
|
2020-08-05 |
2023-06-29 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Ror1-표적 결합 도메인에 대한 항이디오타입 항체 및 관련 조성물 및 방법
|
EP4240756A1
(en)
|
2020-11-04 |
2023-09-13 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
KR20230165771A
(ko)
|
2021-03-03 |
2023-12-05 |
주노 쎄러퓨티크스 인코퍼레이티드 |
T 세포 요법 및 dgk 억제제의 조합
|
US20240168012A1
(en)
|
2021-03-22 |
2024-05-23 |
Juno Therapeutics, Inc. |
Methods of determining potency of a therapeutic cell composition
|
BR112023020012A2
(pt)
|
2021-03-29 |
2023-11-14 |
Juno Therapeutics Inc |
Combinação de uma terapia de células t que expressam car e um composto imunomodulador para o tratamento de linfoma
|
WO2022212400A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy
|
IL307612A
(en)
|
2021-04-16 |
2023-12-01 |
Celgene Corp |
Combined therapies with BCMA-directed T-cell therapy
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
US20240041929A1
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|
WO2024097905A1
(en)
|
2022-11-02 |
2024-05-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|
WO2024124132A1
(en)
|
2022-12-09 |
2024-06-13 |
Juno Therapeutics, Inc. |
Machine learning methods for predicting cell phenotype using holographic imaging
|
WO2024129778A2
(en)
|
2022-12-13 |
2024-06-20 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereof
|